N-Methyl-1-deoxynojirimycin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

N-Methylmoranoline (MOR 14)是 α-glucosidase 的抑制剂。

N-Methylmoranoline (MOR 14) is an α-glucosidase inhibitor.

N-Methylmoranoline decreases the alpha-1,6-glucosidase activity to approximately 20%, reduces the glycogen breakdown, and attenuates the lactate accumulation at both 10 and 30 minutes of ischemia. MOR-14 is protective against postischemic left ventricular dysfunction through the inhibition of glycogenolysis in the isolated rat heart.

N-Methylmoranoline dose-dependently decreases the α-1,6-glucosidase activity in rabbit heart extract. The myocardial uptake of a considerable amount of N-Methylmoranoline is sufficient to fully inhibit alpha-1,6-glucosidase. Preischemic treatment with 25, 50, and 100 mg/kg of N-Methylmoranoline dose-dependently reduces the infarct size without altering the blood pressure or heart rate. MOR-14 significantly increases levels of PKC-ε in the particulate fraction at 20 and 30?min of ischaemia and in the cytosolic fraction at 30?min of ischaemia.

N-甲基-脱氧野尻霉素

Others

Other Targets

Others

———

———

69567-10-8

177.2

C7H15NO4

>98% (HPLC)

———

———

———

(-20℃)

With Ice Pack

≥ 2 years